Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Extended Access Program (EAP) for Perampanel

Trial Profile

An Extended Access Program (EAP) for Perampanel

Status: Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 08 May 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Perampanel (Primary)
  • Indications Partial epilepsies; Tonic-clonic epilepsy
  • Focus Expanded access; Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 04 Dec 2018 Results of post hoc analysis assessing primary generalized tonic-clonic (PGTC) seizures, presented at the 72nd Annual Meeting of the American Epilepsy Society.
    • 27 Apr 2018 Results of post-hoc analysis from this open-label extension phase assessing the effect of common concomitant antiepileptic drugs during adjunctive treatment with Perampanel, presented at the 70th Annual Meeting of the American Academy of Neurology.
    • 27 Apr 2018 Results of a post-hoc analysis from NCT00735397, NCT01618695, NCT01161524 and NCT02307578 studies, presented at the 70th Annual Meeting of the American Academy of Neurology
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top